Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment.

Education

Biotechnology

Eikonoklastes Therapeutics

Eikonoklastes Therapeutics' headquarters in Cincinnati, OH, United States

Bruce Halpryn

Hernan Picard

Vishal Agrawal

Samuel Lee

Tom Finn

Kenneth Morand

Neel Patel

Meyer Frucher

Seward Rutkove

Michael O’Beirne

Mark Tuszynski

Dame Pamela Shaw

Russell Lonser

The Scientific Advisory Team at Eikonoklastes Therapeutics plays a crucial role in guiding the development of innovative tissue factor immunotherapies. Comprising leading experts, the team provides strategic insights and scientific expertise to shape research directions, evaluate therapeutic efficacy, and ensure alignment with cutting-edge advancements in oncology. Their collaborative efforts drive the company's mission to target the tumor microenvironment effectively, advancing novel treatment options for patients.

Scientific Advisory Team

This department oversees the strategic direction and decision-making for the organization.

Executive Governance

This department focuses on developing new ideas and technologies to drive progress and creativity.

Innovation Division

The Leadership Team at Eikonoklastes Therapeutics is responsible for setting strategic direction and overseeing the development of innovative tissue factor immunotherapies. This team, comprised of seasoned professionals, drives decision-making across business operations, research and development, and regulatory pathways, ensuring alignment with the company's mission to transform cancer treatment. Together, they leverage their expertise to foster collaboration, secure funding, and navigate the complexities of bringing cutting-edge therapies to market.

Leadership Team

This department provides strategic oversight and guidance on medical practices and policies.

Medical Leadership

The Research and Development Team at Eikonoklastes Therapeutics spearheads the innovation of tissue factor immunotherapies, focusing on novel therapeutic approaches to disrupt the tumor microenvironment. The team collaborates on drug formulation, mechanism exploration, and preclinical studies to translate groundbreaking research into effective treatments for cancer. With a blend of leadership and inventive expertise, they work to advance pipeline candidates from concept to clinical application.

Eikonoklastes Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Executive Governance

Innovation Division

Leadership Team

Medical Leadership

Research and Development Team

Offices

Eikonoklastes Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Executive Governance

Innovation Division

Leadership Team

Medical Leadership

Research and Development Team

Offices

Related companies